K. Abecassis, S. E. Gibson, M. Martin-Fontecha
FULL PAPER
150.6 [CArC(CH3)3] ppm. MS (EI): m/z (%) = 204 (16) [M+], 189
7.36–7.37 (m, 9 H, CArH ϫ9), 7.44 (s, 1 H, 2-H imid) ppm. 13C
NMR (100 MHz, CDCl3): δ = 31.0 [C(CH3)3], 33.9 [C(CH3)3], 37.9
(72) [M+ – CH3], 162 (29) [M+ – 3CH3 + 3 H], 148 (41) [M+
–
C(CH3)3 + H], 147 (100) [M+ – C(CH3)3], 57 (94) [C(CH3)3+]. (CH2-imid), 71.7 (OCH2), 75.2 [C(C6H5)3], 78.1 (OCH), 90.0
C14H20O (204.15): calcd. C 82.30, H 9.87; found C 82.21, H 9.80.
(CCrH), 90.4 (CCrH), 90.5 (CCrHϫ2), 112.2 [CCrCH(CH2imid)-
OAllyl], 117.1 (CH2=CH), 119.8 (5-CH imid), 123.5 [CCrC-
(CH3)3], 128.1 [CAr(trityl)H ϫ 6], 129.7 [CAr(trityl)H ϫ 9], 134.4
(CH2 =CH), 136.6 (4-C imid), 138.1 (2-CH imid), 142.3
[CAr(trityl) ϫ3], 233.6 (CϵOϫ3) ppm. MS (EI): m/z (%) = 578 (12)
[M+ – 3 CO], 536 (31) [M+ – 3 CO – CH2CH=CH2], 526 (10) [M+ –
Cr(CO)3], 283 (93) [M+ – Cr(CO)3 – CH2CH=CH2], 243 (100)
[CPh3+]. C40H38CrN2O4 (662.74): calcd. C 72.49, H 5.78, N 4.23;
found C 72.45, H 5.70, N 4.14.
Typical Procedure for the Synthesis of an (Arene)tricarbonylchro-
mium(0) Complex
(1-Allyloxymethyl-4-tert-butylbenzene)tricarbonylchromium(0) (9):
Allyl ether 8 (2.68 g, 13.1 mmol) and hexacarbonylchromium(0)
(3.20 g, 14.5 mmol) were added to dry di-n-butyl ether (130 mL)
and THF (15 mL) and the mixture was degassed 10 times and
shielded from ambient light. The reaction mixture was heated un-
der reflux for 24 h at 135 °C and then cooled to room temperature.
The solvents were removed under reduced pressure and the crude
mixture was purified by flash column chromatography (SiO2; hex-
ane/diethyl ether, 100:0 Ǟ 90:10) to yield complex 9 (3.82 g, 86%)
as a yellow solid; m.p. 39–40 °C. Rf = 0.20 (SiO2; hexane/diethyl
(–)-(S)-[4-[2-(Allyloxy)-2-(4-tert-butylphenyl)ethyl]-1-trityl-1H-imid-
azole]tricarbonylchromium(0) [(–)-16]: Complex (–)-16 was prepared
from complex 9 (230 mg, 0.68 mmol), diamine (–)-2 (284 mg,
0.68 mmol) and bromide 15 (660 mg, 2.0 mmol), following the pro-
cedure described for complex (+)-16. 69% yield, yellow solid; ee Ն
99%. [α]2D0 = –23 (c = 1.35, CHCl3). All other analytical data were
identical to those obtained for (+)-16.
ether, 90:10). IR (CHCl ): ν = 1966 (s, νCO), 1891 (s, νCO). 1H NMR
˜
3
(400 MHz): δ = 1.28 [s, 9 H, C(CH3)3], 4.11 (d, J = 5.5 Hz, 2 H,
OCH2CH=CH2), 4.23 (s, 2 H, OCH2Ar), 5.22–5.30 (m, 3 H,
CH=CHHcis and CCrH ϫ2), 5.33 (d, J = 17 Hz, 1 H,
Typical Procedure for Oxidative Decomplexation
CH=CHHtrans), 5.56 (d, J = 7 Hz, 2 H, CCrH ϫ2), 5.93 (ddt, J =
17, 10.5, 5.5 Hz, 1 H, CH=CH2) ppm. 13C NMR (100 MHz): δ =
31.2 [C(CH3)3], 34.0 [C(CH3)3], 70.2 (OCH2CH=CH2), 72.2
(+)-(R)-4-[2-(Allyloxy)-2-(4-tert-butylphenyl)ethyl]-1-trityl-1H-imid-
azole [(+)-17]: Complex (+)-16 (310 mg, 0.47 mmol) was dissolved
in diethyl ether (50 mL) and was left standing for 48 h by the win-
dow. The solvent of the resulting brown suspension was evaporated
under reduced pressure and the residue was purified by flash col-
umn chromatography (SiO2; hexane/ethyl acetate, 90:10 Ǟ 70:30)
to afford compound (+)-17 as a white solid (201 mg, 82%); m.p.
57–58 °C. Rf = 0.32 (SiO2; hexane/ethyl acetate, 70:30). [α]2D0 = +18
(OCH2CCr), 90.6, 92.5 (CCrH ϫ4), 108.0 (CCrCH2), 118.0
(CH=CH2), 121.9 [CCrC(CH3)3], 134.0 (CH=CH2), 233.4 (CϵO
ϫ3) ppm. MS (CI): m/z (%) = 358 (83) [M + NH4+], 341 (100) [M
+ H+], 285 (17) [M + H+ – 2 CO], 284 (38) [M+ – 2 CO], 283 (97)
[M – 2 CO – H+]. C17H20CrO4 (340.08): calcd. C 59.99, H 5.92;
found C 60.04, H 5.94.
(c = 1.30, CHCl ). IR (KBr): ν = 1130 (m, υC–O), 1086 (m, υC–O).
˜
3
1H NMR (400 MHz, CDCl3): δ = 1.33 [s, 9 H, C(CH3)3], 2.87 (dd,
J = 14.5, 6.0 Hz, 1 H, CH2-imid), 3.10 (dd, J = 14.5, 8.0 Hz, 1 H,
CH2-imid), 3.75 (dd, J = 12.5, 5.5 Hz, 1 H, OCH2), 3.91 (dd, J =
12.5, 5.0 Hz, 1 H, OCH2), 4.63 (apparent t, J = 7.0 Hz, 1 H, OCH),
5.09 (d, J = 10.5 Hz, 1 H, CH=CHHcis), 5.16 (d, J = 17.5 Hz, 1
H, CH=CHHtrans), 5.80 (dddd, J = 17.5, 10.5, 5.5, 5.0 Hz, 1 H,
Typical Procedure for Benzylic Enantioselective Alkylation
(+)-(R)-[4-[2-(Allyloxy)-2-(4-tert-butylphenyl)ethyl]-1-trityl-1H-imid-
azole]tricarbonylchromium(0) [(+)-16]: n-Butyllithium (0.6 mL,
2.5 in hexane, 1.5 mmol) was added dropwise to a stirred solution
of diamine (+)-2 (313 mg, 0.74 mmol) in THF (7 mL) at –78 °C.
The solution was warmed to room temperature over a period of
30 min. The resulting deep red solution was then recooled to
–78 °C. A solution of heat-gun-dried lithium chloride (32 mg,
0.74 mmol) in THF (6 mL) was added through a cannula and the
reaction mixture was stirred for a further 5 min before a precooled
solution (–78 °C) of complex 9 (230 mg, 0.68 mmol) in THF (7 mL)
was added dropwise through a cannula. The reaction was stirred
at –78 °C for 45 min before a solution of compound 15 (653 mg,
1.9 mmol) in THF was added through a cannula. Stirring was con-
tinued for a further 2 h at –78 °C and then the reaction mixture was
quenched with methanol (2 mL) and the solvents were removed in
vacuo to give a yellow solid. Purification of the crude product by
flash column chromatography (SiO2; hexane/ethyl acetate, 80:20 Ǟ
60:40) yielded complex 16 (327 mg, 73%) as a yellow solid; m.p.
60–61 °C. Rf = 0.31 (SiO2; hexane/ethyl acetate, 70:30). Enantio-
metric excess was determined by HPLC analysis (Chiralcel OD-H,
n-hexane/iPrOH, 90:10, 1.0 mL/min, 330 nm); (R)-enantiomer
tr = 10.6 min (major); (S)-enantiomer tr = 24.0 min (minor): Ն 99%
CH=CH2), 6.49 (s, 1 H, 5-H imid), 7.10–7.12 [m, 6 H, CAr(trityl)
H
ϫ6], 7.22 (d, J = 8.0 Hz, 2 H, CArHϫ2), 7.29–7.37 [m, 12 H,
CAr(trityl)H ϫ 9, CArH ϫ 2 and 2-H imid] ppm. 13C NMR
(100 MHz, CDCl3): δ = 31.4 [C(CH3)3], 34.5 [C(CH3)3], 37.5 (CH2-
imid), 69.7 (OCH2), 75.1 [C(C6H5)3], 80.8 (OCH), 116.5
(CH2=CH), 119.6 (5-CH imid), 125.1 (CAr H ϫ 2), 126.4
(CArHϫ2), 127.9 [CAr(trityl)Hϫ9], 129.8 [CAr(trityl)Hϫ 6], 135.0
(CH2=CH), 137.8 [CArCH(CH2imid)OAllyl and 2-CH imid], 139.0
(4-C imid), 142.5 [CAr(trityl) ϫ3], 150.1 [CArC(CH3)3] ppm. MS (EI):
m/z (%) = 526 (8) [M+], 485 (34) [M+ – CH2CH=CH2], 283 (13)
[M+ – CPh3], 243 (100) [CPh3+]. C37H38N2O (526.71): calcd. C
84.37, H 7.27, N 5.38; found C 84.45, H 7.18, N 5.38.
(–)-(S)-4-[2-(Allyloxy)-2-(4-tert-butylphenyl)ethyl]-1-trityl-1H-imid-
azole [(–)-17]: Compound (–)-17 was prepared from complex (–)-
16 (220 mg, 0.42 mmol) following the procedure described for imid-
azole (+)-17. 79% yield, white solid. [α]2D0 = –19 (c = 1.60, CHCl3).
All other analytical data were identical to those obtained for (+)-
17.
ee. [α]2D0 = +22 (c = 1.03, CHCl ). IR (KBr): ν = 1959 (s, υ ),
˜
3
CO
1877 (s, υCO ). 1H NMR (400 MHz, CDCl3): δ = 1.30 [s, 9 H,
Typical Procedure for Deallylation
C(CH3)3], 2.92 (dd, J = 14.5, 5.0 Hz, 1 H, CH2-imid), 2.99 (dd, J
= 14.5, 5.0 Hz, 1 H, CH2-imid), 4.02 (dd, J = 12.5, 5.5 Hz, 1 H, (+)-(R)-1-(–4-tert-Butylphenyl)-2-(1-trityl-1H-imidazol-4-yl)ethanol
OCH2), 4.27 (dd, J = 12.5, 5.0 Hz, 1 H, OCH2), 4.47 (apparent t, [(+)-18]: Pd(PPh3)4 (14 mg, 0.013 mmol) was added to a stirred
J = 5.5 Hz, 1 H, OCH), 5.13–5.15 (m, 2 H, CH=CHHcis and solution of allyl protected alcohol (+)-17 (130 mg, 0.25 mmol) in
CCrH), 5.25 (d, J = 17.5 Hz, 1 H, CH=CHHtrans), 5.35 (d, J =
anhydrous methanol (5 mL) under nitrogen. The slightly yellow
7.0 Hz, 1 H, CCrH), 5.42 (d, J = 6.5 Hz, 1 H, CCrH), 5.55 (d, J = solution was stirred for 5 min, and K2CO3 (104 mg, 0.75 mmol)
6.5 Hz, 1 H, CCrH), 5.82 (dddd, J = 17.5, 10.5, 5.5, 5.0 Hz, 1H
CH=CH2), 6.64 (s, 1 H, 5-H imid), 7.14–7.16 (m, 6 H, CArH ϫ6),
was added. The reaction mixture was refluxed for 24 h and once at
room temperature, was neutralised with 1 HCl and extracted with
1610
www.eurjoc.org
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2009, 1606–1611